Non Hodgkin Lymphoma Clinical Trial
CB-Long-Term Safety Study (CB-LTSS)
Summary
This is a non-interventional, long-term safety study of allogeneic CAR-T cell therapy in patients with hematologic malignancies. Its purpose of is to collect long-term observational data to identify and understand potential late side effects in patients who have received CAR-T cell therapies.
Full Description
This is a non-interventional, long-term safety study of allogeneic CAR-T cell therapy in patients with hematologic malignancies. The purpose of this 15-year research study is to collect long-term observational data to identify and understand potential late side effects in patients who have received CAR-T cell therapies as part of a previous Caribou-sponsored study or a Caribou-sponsored special access program.
Eligibility Criteria
Inclusion Criteria:
Written informed consent obtained prior to study-specific activities/enrollment
Received an allogeneic CAR-T therapy and completed or discontinued from a Caribou-sponsored study evaluating an allogeneic CAR-T therapy or was administered an allogeneic CAR-T therapy under a special access mechanism
Exclusion Criteria:
None
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 5 Locations for this study
Scottsdale Arizona, 85258, United States
Irvine California, 92868, United States
Cincinnati Ohio, 45242, United States
Dallas Texas, 75246, United States
Houston Texas, 77030, United States
How clear is this clinincal trial information?